Effects of Whole Body Vibration (WBV) on Musculoskeletal System of Aged Women
NCT ID: NCT01982214
Last Updated: 2015-08-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
225 participants
INTERVENTIONAL
2010-04-30
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary outcome of the project is the pre, mid, and post evaluations of bone. Bone exploration included dual x-ray absorptiometry (DXA) and high resolution peripheral quantitative computed tomography (HR-pQCT). Bone Mass Density (BMD) will be evaluated by DXA at lumbar, femoral levels and humeral, macro and micro-architectures of the cortical and trabecular compartments will be evaluated in distal radius and tibia by HR-pQCT and bone markers will be analyzed longitudinally. The secondary aim is to assess muscle performance and proprioception. Finally will be assessed markers of cartilage degradation and synthesis, no study has been published on this tissue.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Whole Body Vibration in Different Devices on Bone and Muscle Mass in Postmenopausal Women
NCT06222931
Effects of Whole-body Vibration in the Frail Elderly
NCT02090192
Whole-body Vibration Training in Older People
NCT01375790
Effect of Whole Body Vibration on Bone and Fall Related Parameters
NCT00292916
Effects of Whole Body Vibration Therapy on Cognitive Function, Balance, and Quality of Life in Older Adults With Mild Cognitive Impairment
NCT06927882
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sedentary
No intervention
sedentary
No intervention
Vibration
Subjects in this group will be submitted to the WBV for 5 to 20 minutes, 2 or 3 times a week while 12 months. The training included light squats at 35-50 Hz and ended up by stretching and relaxation exercises.
Vibration
Subjects will be submitted to the WBV for 5 to 20 minutes, 2 or 3 times a week with frequencies between 35 to 50 Hz while 12 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sedentary
No intervention
Vibration
Subjects will be submitted to the WBV for 5 to 20 minutes, 2 or 3 times a week with frequencies between 35 to 50 Hz while 12 months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fracture risk Densitometry Risk factors (FRAX) index between 3 and 10%
* Consent form signed
Exclusion Criteria
* Endocrinopathy defined on biological criteria (such as Cushing's disease, hyperparathyroidism, hyperthyroidism, hypogonadism),
* Smoking habits (more than 5 cigarettes per day), chronic alcoholism,
* Treatments received in the previous 6 months affecting bone metabolism such as anabolics, anti-osteoporotic treatment, corticosteroids.
* Having a prosthesis (femur and knee),or recently placed metal bouts or plates
* acute thrombotic problems,
* severe heart- and vascular diseases,
* recent injuries due to operation or polyclinical intervention,
* acute hernia, discopathy, spondylolysis,
* epilepsy,
* severe migraine,
* pacemaker,
* every neurodegenerative or neuromuscular disease,
* dementia
55 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association pour le Développement de la Recherche sur l'Appareil Locomoteur dans la Loire
UNKNOWN
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thierry THOMAS, MD PhD
Role: PRINCIPAL_INVESTIGATOR
CHU de Saint-Etienne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-A00896-51
Identifier Type: OTHER
Identifier Source: secondary_id
0908095
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.